药物对比
Gliclazide vs Insulin Icodec
Gliclazide vs Insulin Icodec：每日口服 vs 每周一次胰岛素治疗2型糖尿病。在血糖控制、低血糖、体重和给药方式方面的关键差异。
此页面暂无可用的对比维度。
临床背景
This comparison is triggered when type 2 diabetes patients on oral sulfonylureas like Gliclazide experience inadequate control and consider advancing to insulin therapy with a once-weekly option.
结论
Gliclazide suits patients preferring oral therapy in earlier type 2 diabetes, while Insulin Icodec is preferable for those requiring potent weekly basal insulin, with selection based on individual needs rather than one being inherently better.
全部药物对比